<DOC>
	<DOC>NCT02469922</DOC>
	<brief_summary>Open multicentric study assessing predictive value of 18-FDG PET (SUV max) at 20 Gy during radio-chemotherapy, on the loco-regional control after 2 years</brief_summary>
	<brief_title>Positron Emission Tomography (PET) During Radio-chemotherapy to Treat Otorhinolaryngological Cancer</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Head and Neck Neoplasms</mesh_term>
	<criteria>Age ≥ 18 years and ≤ 75 years invasive epidermoid carcinoma of head and neck (excluding nasopharyngeal), confirmed by histology locally advanced disease (nonmetastatic stages AJCC IIIIV). AJCC = American Joint Committee on Cancer performance status ECOG ≤ 2. ECOG = Eastern Cooperative Oncology Group no history of irradiation of the head and neck start of radiotherapy within 8 weeks after the pretreatment PET Scan no surgery other than biopsy pregnancy test: negative for women of childbearing potential reliable contraception for a childbearing couple, men and woman must have a reliable contraception during treatment signed informed consent form patient with national health insurance prior radiotherapy or chemotherapy history of other cancer except: cutaneous nonmelanoma tumor and cervix in situ carcinoma unstable conditions (cardiovascular, renal, pulmonary) or systemic (lupus erythematosus, scleroderma) pregnant patient or patient with breastfeeding patient unable to give his consent patient under administrative supervision patient who participates to another clinical trial on experimental drug regular followup impossible for various reasons (familial, economical, social, ...) diabetes accelerated radiotherapy protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>